Heavy tamponade 2 Densiron 68® in routine clinical practice: Anatomical and functional outcomes of a consecutive case series

Eye

Volumn 22, Issue 10, 2008, Pages 1360-1365

  Stappler, T ^a   Heimann, H ^a   Wong, D ^a   Gibran, S K ^a   Groenewald, C ^a   Pearce, I A ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL AND DENTAL MATERIALS; HEAVY TAMPONADE; SILICONE OIL; UNCLASSIFIED DRUG;

ADULT; CATARACT; CLINICAL TRIAL; CONFERENCE PAPER; EMULSION; EYE INFLAMMATION; FEMALE; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA DETACHMENT; RETINA SURGERY; SAFETY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

EID: 54249139578     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.62     Document Type: Conference Paper

References (23)

1. McCuen II BW, de Juan Jr E, Machemer R. Silicone oil in vitreorefinal surgery. Part 1. Surgical techniques. Retina 1985; 5: 189-197.
2. McCuen II BW, de Juan Jr E, Landers III MB, Machemer R. Silicone oil in vitreoretinal surgery. Part 2. Results and complications. Retina 1985; 5: 198-205.
3. Wilson-Holt N, Leaver PK. Extended criteria for vitrectomy and fluid/ silicone oil exchange. Eye 1990; 4(Part 6): 850-854.
4. Kirchhof B. Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol 2004; 242(8): 699-703.
5. Fawcett IM, Williams RL, Wong D. Contact angles of substances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 1994; 232: 438-444.
6. Wettrqvist C, Wong D, William R, Stappler T, Herbert E, Freeburn S. Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 2004; 88: 692-696.
7. Petersen J. The physical and surgical aspects of silicone oil in the vitreous cavity. Graefes Arch Clin Exp Ophthalmol 1987; 225 (6): 452-456.
8. Araiz JJ, Refojo MF, Arroyo MH, Leong Fl, Albert DM, Tolentino FI. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1993; 34(3): 522-530.
9. Winter M, Eberhardt W, Scholz C, Reichenbach A. Failure of potassium siphoning by Muller cells: A new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci 2000; 41 (1): 256-261.
10. Cazabon S, Groenewald C, Pearce IA, Wong D. Visual loss following removal of intraocular silicone oil. Br J Ophthalmol 2005; 89 (7): 799-802.
11. Stolba U, Krepler K, Velikay-Parel M, Binder S. The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 2004; 242(11): 931-936.
12. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N et al Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002; 133: 95-101.
13. Hiscott P, Magee RM, Colthurst M, Lois N, Wong D. Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 2001; 95: 179-183.
14. Kabalin JN. Treatment of post-prostatectomy stress urinary incontinence with periurethral polytetrafluoroethylene paste injection. J Urol 1994; 152(5 Part 1): 1463-1466.
15. Kociok N, Gavranic C, Kirchhof B, Joussen AM. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane. Graefes Arch Clin Exp Ophthalmol 2005; 243(4): 345-358.
16. Tognetto D, Minutola D, Sanguinetti G, Ravalico G. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: A pilot study. Ophthalmology 2005; 112(9): 1574.
17. Sandner D, Engelmann K. First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006; 244: 609-619.
18. Martinez-Castillo V, Zapata MA, Boixadera A, Fonollosa A, Garda-Arumi J. Pars plana vitrectomy, laser retinopexy, and aqueous tamponade for pseudophakic rhegmatogenous retinal detachment. Ophthalmology 2007; 114(2): 297-302.
19. Tanner V, Minihan M, Williamson TH. Management of inferior retinal breaks during pars plana vitrectomy for retinal detachment. Br J Ophthalmol 2001; 85(4): 480-482.
20. Abrams GW, Azen SP, McCuen II BW, Flynn Jr HW, Lai MY, Ryan SJ. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997; 115 (3): 335-344.
21. Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE et al Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 2006; 113(11): 2041-2047.
22. Wong D, Cazabon S, Ali H, Kumar I, Valldeperas X, Groenewald C et al Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy? Ann Acad Med Singapore 2006; 35: 181-184.
23. Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD, HSO Study Group. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): Design issues and implications. Acta Ophthalmol Scand 2007; 85(6): 623-630.